Cargando…
Identification of reversible and druggable pathways to improve beta-cell function and survival in Type 2 diabetes
Targeting β-cell failure could prevent, delay or even partially reverse Type 2 diabetes. However, development of such drugs is limited as the molecular pathogenesis is complex and incompletely understood. Further, while β-cell failure can be modeled experimentally, only some of the molecular changes...
Autores principales: | Sithara, Smithamol, Crowley, Tamsyn, Walder, Ken, Aston-Mourney, Kathryn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9888462/ https://www.ncbi.nlm.nih.gov/pubmed/36709757 http://dx.doi.org/10.1080/19382014.2023.2165368 |
Ejemplares similares
-
Quality of Life and Diabetes in India: A Scoping Review
por: Aarthy, Ramasamy, et al.
Publicado: (2021) -
DRUGGABLE MM THERAPEUTICS: PATHOGENETIC PATHWAYS
por: Ocio, Enrique M
Publicado: (2022) -
Identification of appropriate biochemical parameters and cut points to detect Maturity Onset Diabetes of Young (MODY) in Asian Indians in a clinic setting
por: Aarthy, Ramasamy, et al.
Publicado: (2023) -
Identification of specific metabolic pathways as druggable targets regulating the sensitivity to cyanide poisoning
por: Sips, Patrick Y., et al.
Publicado: (2018) -
Advanced Glycation End-Products and Their Effects on Gut Health
por: Phuong-Nguyen, Kate, et al.
Publicado: (2023)